Otsuka

Otsuka Pharmaceutical Co., Ltd. is a prominent and globally recognized pharmaceutical company based in Japan. Established in 1964, the company has built a strong reputation for its commitment to research, innovation, and the development of cutting-edge pharmaceutical products.

Otsuka Pharmaceutical is engaged in various therapeutic areas, with a focus on mental health, oncology, cardiovascular, and nephrology. They have introduced several groundbreaking medications that have contributed significantly to the improvement of patient outcomes and the overall advancement of medical science.

One of their most well-known products is "Abilify" (aripiprazole), an antipsychotic medication widely prescribed for the treatment of schizophrenia, bipolar disorder, and depression. Additionally, Otsuka is known for its innovative approach to drug delivery systems and formulation technologies, allowing for enhanced patient convenience and compliance.

The company's dedication to research and development has led to strategic collaborations with leading academic institutions and other pharmaceutical companies, fostering a culture of collaboration and exchange of ideas.

Otsuka Pharmaceutical's commitment to corporate social responsibility is also evident through their efforts to address global health challenges, support local communities, and promote sustainability initiatives.

Founded: 1921

Founder: Busaburo Otsuka

Headquarters: Tokyo, Japan

Website: https://www.otsuka.co.jp/